3-30691329-C-A

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_003242.6(TGFBR2):​c.1525-91C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.287 in 1,427,188 control chromosomes in the GnomAD database, including 64,140 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.23 ( 4746 hom., cov: 32)
Exomes 𝑓: 0.29 ( 59394 hom. )

Consequence

TGFBR2
NM_003242.6 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.0520

Publications

17 publications found
Variant links:
Genes affected
TGFBR2 (HGNC:11773): (transforming growth factor beta receptor 2) The protein encoded by this gene is a transmembrane protein that has a protein kinase domain, forms a heterodimeric complex with TGF-beta receptor type-1, and binds TGF-beta. This receptor/ligand complex phosphorylates proteins, which then enter the nucleus and regulate the transcription of genes related to cell proliferation, cell cycle arrest, wound healing, immunosuppression, and tumorigenesis. Mutations in this gene have been associated with Marfan Syndrome, Loeys-Deitz Aortic Aneurysm Syndrome, and the development of various types of tumors. Alternatively spliced transcript variants encoding different isoforms have been characterized. [provided by RefSeq, Aug 2017]
TGFBR2 Gene-Disease associations (from GenCC):
  • familial thoracic aortic aneurysm and aortic dissection
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Loeys-Dietz syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), PanelApp Australia, Genomics England PanelApp, G2P
  • Loeys-Dietz syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 3-30691329-C-A is Benign according to our data. Variant chr3-30691329-C-A is described in CliVar as Benign. Clinvar id is 2687926.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr3-30691329-C-A is described in CliVar as Benign. Clinvar id is 2687926.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr3-30691329-C-A is described in CliVar as Benign. Clinvar id is 2687926.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr3-30691329-C-A is described in CliVar as Benign. Clinvar id is 2687926.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr3-30691329-C-A is described in CliVar as Benign. Clinvar id is 2687926.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr3-30691329-C-A is described in CliVar as Benign. Clinvar id is 2687926.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr3-30691329-C-A is described in CliVar as Benign. Clinvar id is 2687926.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr3-30691329-C-A is described in CliVar as Benign. Clinvar id is 2687926.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr3-30691329-C-A is described in CliVar as Benign. Clinvar id is 2687926.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr3-30691329-C-A is described in CliVar as Benign. Clinvar id is 2687926.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr3-30691329-C-A is described in CliVar as Benign. Clinvar id is 2687926.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr3-30691329-C-A is described in CliVar as Benign. Clinvar id is 2687926.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr3-30691329-C-A is described in CliVar as Benign. Clinvar id is 2687926.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr3-30691329-C-A is described in CliVar as Benign. Clinvar id is 2687926.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr3-30691329-C-A is described in CliVar as Benign. Clinvar id is 2687926.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr3-30691329-C-A is described in CliVar as Benign. Clinvar id is 2687926.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr3-30691329-C-A is described in CliVar as Benign. Clinvar id is 2687926.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr3-30691329-C-A is described in CliVar as Benign. Clinvar id is 2687926.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr3-30691329-C-A is described in CliVar as Benign. Clinvar id is 2687926.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr3-30691329-C-A is described in CliVar as Benign. Clinvar id is 2687926.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr3-30691329-C-A is described in CliVar as Benign. Clinvar id is 2687926.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr3-30691329-C-A is described in CliVar as Benign. Clinvar id is 2687926.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr3-30691329-C-A is described in CliVar as Benign. Clinvar id is 2687926.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.311 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TGFBR2NM_003242.6 linkc.1525-91C>A intron_variant Intron 6 of 6 ENST00000295754.10 NP_003233.4 P37173-1A3QNQ0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TGFBR2ENST00000295754.10 linkc.1525-91C>A intron_variant Intron 6 of 6 1 NM_003242.6 ENSP00000295754.5 P37173-1

Frequencies

GnomAD3 genomes
AF:
0.226
AC:
34320
AN:
152050
Hom.:
4750
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0936
Gnomad AMI
AF:
0.156
Gnomad AMR
AF:
0.151
Gnomad ASJ
AF:
0.173
Gnomad EAS
AF:
0.0948
Gnomad SAS
AF:
0.169
Gnomad FIN
AF:
0.394
Gnomad MID
AF:
0.218
Gnomad NFE
AF:
0.315
Gnomad OTH
AF:
0.213
GnomAD4 exome
AF:
0.294
AC:
375051
AN:
1275020
Hom.:
59394
AF XY:
0.290
AC XY:
185112
AN XY:
637688
show subpopulations
African (AFR)
AF:
0.0880
AC:
2610
AN:
29668
American (AMR)
AF:
0.117
AC:
4335
AN:
37186
Ashkenazi Jewish (ASJ)
AF:
0.168
AC:
4117
AN:
24540
East Asian (EAS)
AF:
0.0870
AC:
3174
AN:
36486
South Asian (SAS)
AF:
0.170
AC:
13358
AN:
78532
European-Finnish (FIN)
AF:
0.396
AC:
18937
AN:
47858
Middle Eastern (MID)
AF:
0.176
AC:
837
AN:
4768
European-Non Finnish (NFE)
AF:
0.326
AC:
313704
AN:
962050
Other (OTH)
AF:
0.259
AC:
13979
AN:
53932
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
13027
26055
39082
52110
65137
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9604
19208
28812
38416
48020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.225
AC:
34303
AN:
152168
Hom.:
4746
Cov.:
32
AF XY:
0.226
AC XY:
16828
AN XY:
74390
show subpopulations
African (AFR)
AF:
0.0934
AC:
3880
AN:
41558
American (AMR)
AF:
0.150
AC:
2300
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.173
AC:
600
AN:
3470
East Asian (EAS)
AF:
0.0944
AC:
488
AN:
5170
South Asian (SAS)
AF:
0.169
AC:
815
AN:
4828
European-Finnish (FIN)
AF:
0.394
AC:
4165
AN:
10570
Middle Eastern (MID)
AF:
0.211
AC:
62
AN:
294
European-Non Finnish (NFE)
AF:
0.315
AC:
21409
AN:
67964
Other (OTH)
AF:
0.209
AC:
442
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
1262
2524
3787
5049
6311
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
360
720
1080
1440
1800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.265
Hom.:
7302
Bravo
AF:
0.202
Asia WGS
AF:
0.131
AC:
456
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 20% of patients studied by a panel of primary immunodeficiencies. Number of patients: 19. Only high quality variants are reported. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
2.6
DANN
Benign
0.61
PhyloP100
0.052
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2276767; hg19: chr3-30732821; COSMIC: COSV55443740; API